Watch Full Webinar (60 mins)

Click below for full slide deck (EN & FR)

Scientific Committee:

Waqqas Afif, MD | Montreal, QC
Jeff McCurdy, MD | Ottawa, ON
Sally Lawrence, MD | Vancouver, BC
Neeraj Narula, MD | Hamilton, ON
Chris Ma, MD | Calgary, AB
Cynthia Seow, MD | Calgary, AB

Abstracts Selected for Webinar

Efficacy and safety of subcutaneous guselkumab rescue therapy in patients with moderately to severely active Crohn’s disease and inadequate response to ustekinumab: results from GALAXI 1, 2 & 3 long-term extension

Anita Afzali, David Wolf, Rupert W. Leong, Rob Van Rampelbergh, Wouter van Duijnhoven, Christian Busse, Takanori Hisamatsu, Julián Panés

Slides created by: Chris Ma

Ustekinumab for Fistulizing Perianal Crohn’s Disease: Week-12 Results from the USTAP Randomized Placebo-Controlled GETAID Trial

Pauline Wils; S. Nancey; E. Messmer; A. Bourreille; A. Buisson; L. Caillo; L. Vuitton; R. Altwegg; X. Hébuterne; O. Ernst; P. Meunier; V. Laurent; D. Laharie; E. Vicaut; L. Peyrin-Biroulet.

Slides created by: Cynthia Seow

Comparative risk of advanced biological agents for serious infections in ulcerative colitis: real-world cohort analysis

Dhruv Ahuja; C. Dziegielewski; K.-H. Yeh; S. B. Patel; S. W. Goodwin; C. Ma; A. N. Ananthakrishnan; N. Singh; V. Jairath; R. Xu; S. Singh.

Slides created by: Neeraj Narula

A healthy dietary pattern and fruit consumption halve relapse risk in Crohn’s disease and ulcerative colitis: a large prospective nationwide study in France

Hélène Sarter, S. Alirol, C. Gower-Rousseau, A. Buisson, L. Dauchet, F. Carbonnel, J-P. Hugot; Pediatric GETAID group

Slides created by: Neeraj Narula

Non-Webinar Abstracts

Efficacy and safety of obefazimod in patients with moderately to severely active ulcerative colitis: results from two phase 3, randomized, double-blind, placebo-controlled 8-week induction trials (ABTECT-1 & ABTECT-2)

Bruce E. Sands, Silvio Danese, Laurent Peyrin-Biroulet, Marla C. Dubinsky, Takanori Hisamatsu, Herbert Tilg, Raja Atreya, Alessandro Armuzzi, Xavier Treton, Frank Baert, Ulrich Seidler, Federico Cataldi, David Jacobstein, Carole Rabbat, Kevin Shan, Gregory DuVall, Britta Siegmund, Parambir S. Dulai, David T. Rubin, Séverine Vermeire

Slides created by: Chris Ma

Efficacy of obefazimod in ABTECT phase 3 induction trials: results of 8-week therapy in subsets of patients with and without prior inadequate response to advanced therapies

Silvio Danese, Bruce E. Sands, Laurent Peyrin-Biroulet, Marla C. Dubinsky, Britta Siegmund, Raja Atreya, Takanori Hisamatsu, Herbert Tilg, Alessandro Armuzzi, Xavier Treton, Frank Baert, Ulrich Seidler, Federico Cataldi, David Jacobstein, Carole Rabbat, Kevin Shan, Gregory DuVall, Parambir S. Dulai, David T. Rubin, Séverine Vermeire

Slides created by: Chris Ma

Changing the course of Crohn’s disease with an early use of adalimumab: the CURE study from the GETAID

Bénédicte Caron, Eléonore Jeanbert, Florian Poullenot, Yoram Bouhnik, Laurent Vuitton, Christophe Reenaers, Stéphane Nancey, Pierre Blanc, Xavier Roblin, Sophie Viennot, Jean-Louis Dupas, Anne-Laure Pelletier, Alain Bourreille, Julien Moreau, Jean Filippi, Maxime Nachury, Guillaume Bouguen, Marc Simon, Lucie Caillo, Antoine Buisson, Lampros Plastaras, Vincent Abitbol, Aurore Aubourg, Meriem Boualit, David Laharie, Laurent Peyrin-Biroulet

Slides created by: Sally Lawrence

Beyond endoscopy: evaluating non-invasive tools for monitoring postoperative Crohn’s disease recurrence

Luisa Bertin, Beatrice Masoni, Sara Ferretti, Alessandro Armuzzi, Chiara Bezzio, Marco Zanconato, Giulia Semprucci, D.G. Ribaldone, Andrea Capello, Giacomo Bodini, Francesco Calabrese, Luca Ceccarelli, Francesca Costa, Lorenzo Bertani, Marco Marino, Luca Navarria, Giuseppe Benevento, Riccardo Sablich, Marta Ascolani, Michele Campigotto, Andrea Buda, Giuseppe Riguccio, Nicola Merlini, Elena Dal Pont, Davide Canova, Edoardo V. Savarino, Federica Zingone

Slides created by: Sally Lawrence

Up-front vedolizumab versus conventional treatment for checkpoint-inhibitor–induced colitis (VEICO): Open-label randomized phase 2 trial

Emilie Kristine Dahl, Jacob T. Bjerrum, Katrine R. Christensen, Anna B. Wozniak, Johanna F. Ilvemark, Mette M. Koch, Philippe Blanche, Niels D. Vad, Marco Donia, Inge Marie Svane, Jørgen B. Seidelin

Slides created by: Sally Lawrence

Postoperative recurrence in Crohn’s disease: comparing proactive (prophylactic) versus reactive management after ileocecal resection — a multicenter retrospective study

Luisa Bertin, Beatrice Masoni, Sara Ferretti, Alessandro Armuzzi, Chiara Bezzio, Marco Zanconato, Giulia Semprucci, D.G. Ribaldone, Andrea Capello, Giacomo Bodini, Andrea Pasta, Francesco Calabrese, Luca Ceccarelli, Francesca Costa, Lorenzo Bertani, Marco Marino, Luca Navarria, Giuseppe Benevento, Riccardo Sablich, Marta Ascolani, Andrea Buda, Giuseppe Riguccio, Nicola Merlini, Elena Dal Pont, Davide Canova, Edoardo V. Savarino, Federica Zingone

Slides created by: Neeraj Narula

Efficacy and safety of subcutaneous guselkumab (GUS) induction and maintenance in ulcerative colitis: ASTRO phase 3 results through Week 48

J. Allegretti; L. Peyrin-Biroulet; M. Long; M. Germinaro; T. Baker; M. Kavalam; Y. Alvarez; K. Hertzog; S. Jorgens; H. Zhang; L. Jiang; T. Hisamatsu; D. T. Rubin; S. Danese

Slides created by: Cynthia Seow

Treatment of Crohn’s Complex Perianal Fistulas With Micro-Fragmented Autologous Adipose Tissue (M-Fat): ATTIC Randomized Controlled Trial

Silvio Laureti; Luca Sofo; Andrea Cappelli; Federico Colombo; Giacomo Luglio; Simone Scaringi; Chiara Isopi; Federico Sacchetti; Giacomo Clerico; Paolo Danelli; Marco Cricrì; Francesco Ficari; Lorenzo Gentilini; Anisha Menon; Paolo Gionchetti; Gianluca Poggioli; Antonino Spinelli

Slides created by: Cynthia Seow